Literature DB >> 15797547

Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.

Ikuru Yazawa1, Benoit I Giasson, Ryogen Sasaki, Bin Zhang, Sonali Joyce, Kunihiro Uryu, John Q Trojanowski, Virginia M-Y Lee.   

Abstract

Transgenic (Tg) mice overexpressing human wild-type alpha-synuclein in oligodendrocytes under the control of the 2,' 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) promoter are shown here to recapitulate features of multiple system atrophy (MSA), including the accumulation of filamentous human alpha-synuclein aggregates in oligodendrocytes linked to their degeneration and autophagocytosis of myelin. Significantly, endogenous mouse alpha-synuclein also accumulated in normal and degenerating axons and axon terminals in association with oligodendroglia and neuron loss and slowly progressive motor impairments. Our studies demonstrate that overexpression of alpha-synuclein in oligodendrocytes of mice results in MSA-like degeneration in the CNS and that alpha-synuclein inclusions in oligodendrocytes participate in the degeneration of neurons in MSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797547     DOI: 10.1016/j.neuron.2005.01.032

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  126 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 2.  Intercellular (mis)communication in neurodegenerative disease.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

Review 3.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

4.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

5.  Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

Authors:  Lee J Martin; Yan Pan; Ann C Price; Wanda Sterling; Neal G Copeland; Nancy A Jenkins; Donald L Price; Michael K Lee
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

6.  Proceedings of the 2nd International Meeting on Multiple System Atrophy, June 17-18, 2004, Rome, Italy.

Authors: 
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

7.  Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function.

Authors:  Andreu Viader; Judith P Golden; Robert H Baloh; Robert E Schmidt; Daniel A Hunter; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

8.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

Review 9.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

10.  Bladder dysfunction in a transgenic mouse model of multiple system atrophy.

Authors:  Mathieu Boudes; Pieter Uvin; Silvia Pinto; Thomas Voets; Clare J Fowler; Gregor K Wenning; Dirk De Ridder; Nadia Stefanova
Journal:  Mov Disord       Date:  2013-02-20       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.